We sit down with you and build your perfect lead list. Book a call with founders.

Abridge Analysis: $774M Raised

What is Abridge?

Abridge specializes in transforming clinical conversations into AI-generated notes. Their unique Contextual Reasoning Engine enables real-time, clinically useful documentation. This innovation significantly reduces clinician workload and enhances patient care outcomes.

HQ Country
Pittsburgh, United States
Employees
201-500
Founded
2018
Industry
SaaS, HealthTech, AI/ML

Product Features & Capabilities

  • AI-generated clinical documentation
  • Contextual Reasoning Engine for real-time notes
  • Integration with Epic for seamless workflows
  • Solutions for clinicians, revenue cycle, and nursing
  • Impact Calculator for measuring outcomes.

How much Abridge raised

Series E - $316M

June 12, 2025
Lead Investor: Andreessen Horowitz, Khosla Ventures

Series D - $250M

February 17, 2025
Lead Investor: Elad Gil, IVP, Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health, Kaiser Permanente Ventures, Lightspeed Venture Partners, NVentures, Redpoint Ventures, Spark Capital, SV Angel

Series C - $150M

February 22, 2024
Lead Investor: Lightspeed Venture Partners, Redpoint Ventures, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Kaiser Permanente Ventures, CVS Health, IVP, Partners HealthCare, Mass General Brigham

Series B - $30M

October 26, 2023
Lead Investor: Spark Capital, Bessemer Venture Partners, CVS Health, Kaiser Permanente Ventures, LifePoint Health, Mayo Clinic, American College of Cardiology, University of California

Series A - $12.5M

August 11, 2022
Lead Investor: Wittington Ventures, Union Square Ventures, Bessemer Venture Partners, Pillar VC, UPMC, Whistler Capital Partners, Yoshua Bengio

Series A - $15M

October 6, 2020
Lead Investor: Union Square Ventures, UPMC, Bessemer Venture Partners, KdT Ventures, Pillar VC

Financial Overview

$774MTotal Raised
Series E$316M
June 12, 2025
Investors: Andreessen Horowitz, Khosla Ventures
Series D$250M
February 17, 2025
Investors: Elad Gil, IVP, Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health, Kaiser Permanente Ventures, Lightspeed Venture Partners, NVentures, Redpoint Ventures, Spark Capital, SV Angel
Series C$150M
February 22, 2024
Investors: Lightspeed Venture Partners, Redpoint Ventures, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Kaiser Permanente Ventures, CVS Health, IVP, Partners HealthCare, Mass General Brigham
Series B$30M
October 26, 2023
Investors: Spark Capital, Bessemer Venture Partners, CVS Health, Kaiser Permanente Ventures, LifePoint Health, Mayo Clinic, American College of Cardiology, University of California
Series A$12.5M
August 11, 2022
Investors: Wittington Ventures, Union Square Ventures, Bessemer Venture Partners, Pillar VC, UPMC, Whistler Capital Partners, Yoshua Bengio
Series A$15M
October 6, 2020
Investors: Union Square Ventures, UPMC, Bessemer Venture Partners, KdT Ventures, Pillar VC
Want to research more data points on Abridge?
Start with Extruct